Semax

Hör nicht zu

Hör nicht zu

Semax is a synthetic neuropeptide with nootropic and neuroprotective effects, derived from an adrenocorticotropic hormone (ACTH) fragment.

Artikelnummer: 198885 Kategorie:
Teile deine Liebe

The amino acid sequence of Semax is H-Met-Glu-His-Phe-Pro-Gly-Pro-OH. Carefully modified based on the fourth to seventh amino acids of a fragment derived from adrenocorticotropes Hormon (ACTH), this modification removes ACTH’s inherent side effects.

Preserving and in some cases enhancing neuroactive properties and stability, Semax demonstrates superior outcomes specifically related to neuroprotection and various forms of cognitive enhancement.

Enhancing learning and memory processes, Konzentration, and information processing speed are unique advantages the substance provides.

Direct influence on synaptic plasticity (hippocampal and cerebral cortex being prime examples) is what sets Semax apart; cognitive function is boosted by the body’s own physiological regulation, without addiction or fatigue.

Anxiety resistance and adaptogenic effects are also well documented, though immunomodulation is still being studied.

Gesamt, all the currently known neurotherapeutic effects of Semax hold great promise; Alzheimer’s, Parkinson’s, glaucoma, Depression, and many other conditions of a neurological or psychiatric nature, will benefit from a truly effective cognitive enhancer.

Sequenz

Ac-Met-Glu-His-Phe-Pro-Gly-Pro

CAS-Nummer

80714-61-0

Molekulare Formel

C39H54N10O10S

Molekulargewicht

854.99

Research Of Semax

1.Clinical Applications and Research Findings

Early approval was given in the 1990s for treating encephalopathy and stroke (circulatory related being the primary example), along with numerous neurological complications of non-insulin dependent diabetes.

Continuous research has since shown Semax to counteract a wide array of damaging brain stimuli ischemia, Hypoxie, Toxizität, and oxidative stress to name a few.

Potent antioxidant activity, improved intracellular energy metabolism within the brain, and enhanced survival of brain cells are all documented effects.

2.Neuroprotektive Wirkungen

When the brain suffers damage from hypoxia, toxic substances, oxidativer Stress, or direct trauma, brain cells continuously die or lose function; irreversible injury follows as a result.

Semax has been demonstrated to inhibit or at least interrupt this process through various multi-target effects.

Experimental evidence shows upregulation of specific neurotrophic factors as one mechanism; activation of the TRKB receptor follows, rapidly initiating neuronal differentiation and subsequent repair pathwaysmaximizing the potential for neuronal survival.

Suppressing the more acute toxicity of excitatory amino acids is another key action, as well as the inhibition of the initiation phase of cellular programmed apoptosis itself.

Clinical trials indicate effective reduction of infarct size and alleviation of cerebral edema in ischemic stroke patients; a solid foundation for all aspects of recovery (physical and psychological) is provided by Semax.

3.Kognitive Verbesserung

Semax regulates the systemic balance of several neurotransmittersdopamine, serotonin, Acetylcholin to name a fewcreating an efficient, stable environment within the nervous system.

Synaptic plasticity in critical regions (hippocampus being prime examples, prefrontal also important) is influenced by this regulation.

Physiologically regulating brain function leads to improved cognitive abilities; learning and memory (Bildung, consolidation and retrieval) are all enhanced, attention span increased, information processing speed improved and mental clarity restored.

Traditional stimulants cause the associated tension and anxiety that Semax completely avoids.

4.Anti-anxiety and Adaptogenic Effects

The hypothalamic-pituitary-adrenal (HPA) axis governs the body’s stress response.

Stabilizing this system is what Semax truly excels atabnormal cortisol levels and all the pathological damage they cause from chronic stress are lessened.

5.Neuro-Repair and Neurotrophic Effects

Activating aus dem Gehirn stammender neurotropher Faktor (BDNF)/TrkB and other growth factor pathways, Semax provides a form of ‘revitalizationto neurons, both structurally and functionally.

Axonal and network level reorganization can be achieved.

Surviving neurons can and do, in part at least, return to a near normal state of function.

Selank and Semax together are a powerful combination.

This combination represents a promising neuroprotective strategy.

Echtheitszertifikat

HPLC

MS

(1) Dmitrieva, V. G.; Povarova, O. V.; Skvortsova, V. ICH.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Semax und Pro-Gly-Pro aktivieren die Transkription von Neurotrophinen und ihren Rezeptorgenen nach zerebraler Ischämie. Zelluläre und molekulare Neurobiologie 2009, 30 (1), 71-79. DOI: 10.1007/s10571-009-9432-0.

(2) Eremin, K. O.; Kudrin, V. S.; Saransari, P.; Produkt, S. S.; Grivennikow, ICH. A.; Myasoedov, N. F.; Rayevsky, K. S. Hör nicht zu, Ein ACTH(4-10) Analog mit nootropischen Eigenschaften, Aktiviert dopaminerge und serotoninerge Gehirnsysteme bei Nagetieren. Neurochemische Forschung 2005, 30 (12), 1493-1500. DOI: 10.1007/s11064-005-8826-8.

(3) Glasova, N. Y.; Manchenko, D. M.; Wolodina, M. A.; Merchieva, S. A.; Andreeva, L. A.; Kudrin, V. S.; Myasoedov, N. F.; Levitskaya, N. G. Hör nicht zu, synthetisches ACTH(4–10) analog, schwächt Verhaltens- und neurochemische Veränderungen nach Fluvoxamin-Exposition im frühen Leben bei weißen Ratten ab. Neuropeptide 2021, 86. DOI: 10.1016/j.npep.2020.102114.

(4) Kosten, N. V.; Sokolow, O.; Gabaeva, M. V.; Grivennikow, ICH. A.; Andreeva, L. A.; Miasoedov, N. F.; Zozulia, A. A. [Semax und Selank hemmen die Enkephalin abbauenden Enzyme aus menschlichem Serum]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/A:1011373002885 Von NLM Medline.

(5) Medwedewa, E. V.; Dmitrieva, V. G.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Hör nicht zu, ein Analogon von ACTH(4−7), reguliert die Expression von Immunantwortgenen während einer ischämischen Hirnverletzung bei Ratten. Molekulargenetik und Genomik 2017, 292 (3), 635-653. DOI: 10.1007/s00438-017-1297-1.

(6) Pae, C.-U. Therapeutische Möglichkeit von „Semax“ bei Depressionen. ZNS-Spektren 2014, 13 (1), 20-21. DOI: 10.1017/s1092852900016102.

(7) Wlassowa, ICH. M.; Buravtcov, D. E.; Saletsky, A. M. Lumineszenzanalyse von Blutbestandteilen in Studien zu den neuroprotektiven Eigenschaften des Arzneimittels „Semax“ bei zerebraler Ischämie. Zeitschrift für Angewandte Spektroskopie 2009, 76 (1), 121-126. DOI: 10.1007/s10812-009-9141-y.

Sequenz:

Ac-Met-Glu-His-Phe-Pro-Gly-Pro

CAS:

80714-61-0

M.W:

823.928 g/mol

Heim Suchen WhatsApp Dienstleistungen Produkt